SEC Form 4 · STOCK Act

Insider buys that paid off for the people who copied them.

$ZSTK

ZeroStack Corp.

+206.0%

Michael Heinrich, Executive Chair, bought $3.5M. Filed Jul 20, 6:31 PM ET.

COPIED JUL 21

$1,000 copied at the first price after the filing (Jul 21 open, $1.66) was $3,060 30 trading days later.

Example. Of 339 buys of $100K or more filed Jun 29 to Sep 11, the median lost 5.3% and 67.8% lost money over the same 30 trading days. Not investment advice.

Officers and directors must report their own stock purchases within two business days. We list every one, largest first, with what copying it would have returned.

A free account keeps a watchlist. No password: we email you a link.

TNGXSell

Tango Therapeutics, Inc.

Adam Crystal · President, R&D

$661K−18.9%Oct 5
TNGXSell

Tango Therapeutics, Inc.

Jessica Newcomb · Principal Accounting Officer

$199K−12.2%Sep 24
TNGXSell

Tango Therapeutics, Inc.

Adam Crystal · President, R&D

$604K−18.9%Sep 3
TNGXSell

Tango Therapeutics, Inc.

Adam Crystal · President, R&D

$736K−18.9%Aug 5
TNGXSell

Tango Therapeutics, Inc.

Adam Crystal · President, R&D

$799K−18.9%Jul 2
TNGXSell

Tango Therapeutics, Inc.

Adam Crystal · President, R&D

$618K−18.9%Jun 3
TNGXSell

Tango Therapeutics, Inc.

Adam Crystal · Pres, R, D

$573K−19.0%May 5
TNGXSell

Tango Therapeutics, Inc.

Adam Crystal · Pres, R, D

$962K−25.0%Apr 16
TNGXSell

Tango Therapeutics, Inc.

Adam Crystal · Pres, R, D

$572K−19.0%Apr 2
TNGXSell

Tango Therapeutics, Inc.

Adam Crystal · Pres, R, D

$241K−10.0%Mar 27
TNGXSell

Tango Therapeutics, Inc.

Adam Crystal · Pres, R, D

$304K−15.0%Mar 9
TNGXSell

Tango Therapeutics, Inc.

Adam Crystal · Pres, R, D

$694K−29.0%Feb 27
TNGXSell

Tango Therapeutics, Inc.

Ecor1 Capital, LLC · 10% owner

$8.4M−20.0%Nov 8
TNGXSell

Tango Therapeutics, Inc.

Boxer Capital Management, LLC · Insider

$9.7M−22.0%Nov 7
TNGXSell

Tango Therapeutics, Inc.

Boxer Capital Management, LLC · Insider

$4.3M−4.0%Oct 28
TNGXSell

Tango Therapeutics, Inc.

Boxer Capital Management, LLC · Insider

$6.1M−6.0%Oct 23
TNGXSell

Tango Therapeutics, Inc.

Third Rock Ventures Iv, L.P. · 10% owner

$710KSep 17
TNGXSell

Tango Therapeutics, Inc.

Third Rock Ventures Iv, L.P. · 10% owner

$867KSep 9
TNGXSell

Tango Therapeutics, Inc.

Third Rock Ventures Iv, L.P. · 10% owner

$2.0M−1.0%Sep 4
TNGXSell

Tango Therapeutics, Inc.

Third Rock Ventures Iv, L.P. · 10% owner

$289KAug 29
TNGXSell

Tango Therapeutics, Inc.

Third Rock Ventures Iv, L.P. · 10% owner

$2.8M−2.0%Aug 20
TNGXSell

Tango Therapeutics, Inc.

Third Rock Ventures Iv, L.P. · 10% owner

$2.3M−1.0%Aug 1
TNGXSell

Tango Therapeutics, Inc.

Third Rock Ventures Iv, L.P. · 10% owner

$492KJul 30
TNGXSell

Tango Therapeutics, Inc.

Third Rock Ventures Iv, L.P. · 10% owner

$3.0M−2.0%Jul 26
TNGXSell

Tango Therapeutics, Inc.

Third Rock Ventures Iv, L.P. · 10% owner

$3.8M−2.0%Jul 24
TNGXSell

Tango Therapeutics, Inc.

Third Rock Ventures Iv, L.P. · 10% owner

$1.9M−1.0%Jul 22
TNGXSell

Tango Therapeutics, Inc.

Third Rock Ventures Iv, L.P. · 10% owner

$5.4M−3.0%Jul 18
TNGXSell

Tango Therapeutics, Inc.

Mva Investors, LLC · Insider

$2.1M−68.0%Jul 2
TNGXSell

Tango Therapeutics, Inc.

Mva Investors, LLC · Insider

$986K−29.0%Jun 7
TNGXSell

Tango Therapeutics, Inc.

Lesley Ann Calhoun · Director

$36K−44.0%Jun 7
TNGXSell

Tango Therapeutics, Inc.

Mva Investors, LLC · Insider

$1.6M−30.0%May 3
TNGXSell

Tango Therapeutics, Inc.

Third Rock Ventures Iv, L.P. · 10% owner

$1.9M−1.0%Feb 21
TNGXSell

Tango Therapeutics, Inc.

Adam Crystal · Insider

$105K−7.0%Feb 8
TNGXSell

Tango Therapeutics, Inc.

Barbara Weber · CEO

$115K−1.0%Feb 8
TNGXSell

Tango Therapeutics, Inc.

Douglas Barry · General Counsel

$35K−6.0%Feb 8
TNGXSell

Tango Therapeutics, Inc.

Daniella Beckman · CFO

$47K−3.0%Feb 8
TNGXSell

Tango Therapeutics, Inc.

Adam Crystal · Insider

$63K−8.0%Nov 2
TNGXSell

Tango Therapeutics, Inc.

Boxer Capital, LLC · Insider

$2.2M−2.0%Oct 11

Filings come from SEC EDGAR within a minute of the SEC accepting them. Without Pro, each one unlocks 4 hours later. Not investment advice.

Questions

Where does the data come from?

Corporate insider trades come straight from SEC Form 4 filings, pulled from EDGAR within a minute of each filing. Congress trades come from STOCK Act disclosures. All of it is public and free to browse here, and Pro sees the newest filings first.

How often is it updated?

Every minute from 6 AM to 10 PM New York time on weekdays, the hours the SEC accepts filings. Pro sees each filing as it lands. Without Pro, a filing unlocks 4 hours after the SEC accepts it.

Is following insider trades legal?

Yes. Insiders are legally required to disclose their trades within a few days. Acting on those public disclosures is completely legal. Trading on private, non-public information is illegal, but that's a different thing.

What does the iPhone app add?

We're building an iPhone app that alerts you to new filings and, if you choose, copies a buy into your own brokerage after you approve it. It isn't out yet, and the waitlist is free.